100% tevredenheidsgarantie Direct beschikbaar na je betaling Lees online óf als PDF Geen vaste maandelijkse kosten 4.2 TrustPilot
logo-home
Samenvatting

Summary HPI4001 - Case 3: Economic evaluation of health interventions

Beoordeling
-
Verkocht
1
Pagina's
17
Geüpload op
05-01-2022
Geschreven in
2021/2022

Case 3 of the HPI4001 module











Oeps! We kunnen je document nu niet laden. Probeer het nog eens of neem contact op met support.

Documentinformatie

Geüpload op
5 januari 2022
Aantal pagina's
17
Geschreven in
2021/2022
Type
Samenvatting

Voorbeeld van de inhoud

Case 3: Economic evaluation of health interventions

Learning goals
1. Why do we need to conduct economic evaluation of healthcare innovations?
2. What is an economic evaluation and what are the types of economic evaluations?
3. How do we present and interpret the results of an economic evaluation?
4. Describe the two main methods of economic evaluation (i.e., model-based and trial-based
economic evaluation)
a. What are the pros and cons of each method?


Keywords of the case
Cost benefit analysis, cost-effectiveness analysis, cost-minimisation analysis, cost-utility analysis,
cost-effectiveness plane, economic evaluation, model-based economic evaluation, trial-based
economic evaluation, QALY, incremental cost-effectiveness ratio and cost-effectiveness thresholds.


Literature
- Chisholm D, Evans D. Economic evaluation in health: saving money or improving care? Journal of
Medical Economics 2007; 10: 325–337
- Drummond M, Sculpher M, Claxton K, Stoddart G, Torrance G. Methods for the economic
evaluation of health care programmes. 2015. Fourth edition. Oxford. Chapter 1 and Chapter 4 (until
4.3.2 included)
- Evers, S. M., Goossens, M. E., Ament, A. J., & Maarse, J. A. (2001). Economic evaluation in stroke
research. An introduction. Cerebrovasc Dis, 11(2), 82-91.
- Kernick DP. Introduction to health economics for the medical practitioner. Postgrad Med J. 2003
Mar;79(929):147-50.
- Petrou S, Gray A. Economic evaluation alongside randomised controlled trials: design, conduct,
analysis, and reporting. BMJ. 2011 Apr 7;342:d1548.
- Petrou S, Gray A. Economic evaluation using decision analytical modelling: design, conduct, analysis,
and reporting. BMJ. 2011 Apr 11;342:d1766
- Sculpher MJ, Claxton K, Drummond M, McCabe C. Whither trial-based economic evaluation for
health care decision making? Health-Econ. 2006 Jul; 15(7): 677-87

,1. Why do we need to conduct economic evaluation of healthcare innovations?
Importance of economic evaluations
There is a tension between:
- Limited financial possibilities
à Healthcare budget constraint
- Unlimited needs/ Increase of healthcare needs (costs)
à New expensive treatments/ interventions/ innovations
There are not enough resources to meet all of society’s needs and therefore, choices have to be
made.


Importance of health economic evaluation
- Increased attention to issues of costs and efficiency
- Increased use of economic data in decision about the reimbursement or pricing of health
technologies
- Formal use of economic data (e.g., drug reimbursement)
à Fourth hurdle to market access


Goal of decision makers
- To efficiently allocate scarce healthcare resources
- To maximise health of the population with limited resources


Health Technology Assessment
“HTA is a multidisciplinary process that summarizes information about the medical, social, economic,
and ethical issues related to the use of health technology in a systematic, transparent, unbiased,
robust manner” (European Commission). Its aims are:
- To inform decision making
- To improve the quality of care by promoting an appropriate and rational use of health
technologies
- To facilitate planning for the introduction and diffusion of new technologies


Economic evaluation
An economic evaluation is a branch of HTA, as for instance epidemiological, judicial, ethical and
social aspects. Economic evaluation looks at the costs and effects of (new) interventions.
à Provide a framework for identifying and comparing the costs and benefits of different options.
à Inform decision makers about efficient healthcare allocation

, Uncertainty in economic evaluation
- Structural uncertainty (assumptions, methods)
- Parameter uncertainty (e.g., treatment effect)
- Heterogeneity (sex, age, subgroups)
Because this still needs to be addressed, a sensitivity analysis can be performed (one-way vs.
probabilistic)


Key payer requirements




Criteria used to assess medicinal products

Maak kennis met de verkoper

Seller avatar
De reputatie van een verkoper is gebaseerd op het aantal documenten dat iemand tegen betaling verkocht heeft en de beoordelingen die voor die items ontvangen zijn. Er zijn drie niveau’s te onderscheiden: brons, zilver en goud. Hoe beter de reputatie, hoe meer de kwaliteit van zijn of haar werk te vertrouwen is.
1998Eva Maastricht University
Bekijk profiel
Volgen Je moet ingelogd zijn om studenten of vakken te kunnen volgen
Verkocht
201
Lid sinds
7 jaar
Aantal volgers
114
Documenten
39
Laatst verkocht
1 week geleden

4,1

17 beoordelingen

5
5
4
10
3
1
2
0
1
1

Recent door jou bekeken

Waarom studenten kiezen voor Stuvia

Gemaakt door medestudenten, geverifieerd door reviews

Kwaliteit die je kunt vertrouwen: geschreven door studenten die slaagden en beoordeeld door anderen die dit document gebruikten.

Niet tevreden? Kies een ander document

Geen zorgen! Je kunt voor hetzelfde geld direct een ander document kiezen dat beter past bij wat je zoekt.

Betaal zoals je wilt, start meteen met leren

Geen abonnement, geen verplichtingen. Betaal zoals je gewend bent via iDeal of creditcard en download je PDF-document meteen.

Student with book image

“Gekocht, gedownload en geslaagd. Zo makkelijk kan het dus zijn.”

Alisha Student

Veelgestelde vragen